phrykt

Amgen (AMGN) shares outstanding: 540.9M

Amgen had 540.9M shares outstanding on Oct 29, 2026, up 0.5% from 538.5M a year earlier.

From Amgen's filings with the SEC · AMGN stock page

Amgen shares outstanding by year

533.6M2022535.2M2023537.5M2024538.5M2025540.9M2026

#229 of 3,715 US companies by shares outstanding · See the full ranking

Year endedShares outstandingChange
Oct 29, 2026540.9M+0%
Oct 30, 2025538.5M+0%
Oct 25, 2024537.5M+0%
Oct 26, 2023535.2M+0%
Oct 31, 2022533.6M–

Shares outstanding of similar companies

Companies in the same industry as Amgen, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.

CompanyShares outstanding, latest yearYear ended
Recursion Pharmaceuticals622.8MOct 26, 2026
Amgen540.9MOct 29, 2026
Iovance Biotherapeutics462.7MOct 27, 2026
Moderna404.6MOct 30, 2026
Taysha Gene Therapies326.0MNov 12, 2026
DBV Technologies314.4MOct 26, 2026
Sana Biotechnology299.6MOct 29, 2026

Questions and answers

What is Amgen's shares outstanding?

Amgen had 540.9M shares outstanding on Oct 29, 2026, up 0.5% from 538.5M a year earlier.

Numbers as reported in Amgen's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology